Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Statera Biopharma, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 22 | 21 | −1 |
| Shares | 1.07M | 787.5K | −280.6K (−26.3%) |
| Value | $5.61M | $4.31M | −$1.30M (−23.2%) |
New holders (3)
Institutions that held Statera Biopharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 23,995 | $131.0K | 0.00% |
| Sequoia Financial Advisors, LLC | 12,588 | $69.0K | 0.00% |
| FMR LLC | 100 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Statera Biopharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| ARS Investment Partners, LLC | 36,981 | $194.0K |
| Citadel Advisors LLC | 36,626 | $192.0K |
| Northwestern Mutual Wealth Management Co | 125 | $1.00K |
| Bank of Montreal | 31 | $0 |